GovTwin / Companies / IBN Sina Pharmaceutical

IBN Sina Pharmaceutical

DSE: IBNSINA

Pharmaceuticals · Islami Bank-linked

IBN Sina Pharmaceutical Industry is a listed Bangladeshi pharmaceutical manufacturer associated with the Islami Bank-linked group of institutions. It produces human medicines and also has a presence in healthcare services.

Business: Manufacture and marketing of human pharmaceutical formulations, including herbal and Unani-Ayurvedic products, alongside a healthcare and diagnostic services presence within the affiliated group.

Market data

Market capitalisation

9,686 mn BDT

Paid-up capital

312 mn BDT

Outstanding shares

31,243,627

Last price

314.2 BDT

Listed

1989

Market category

A

Source: Dhaka Stock Exchange, fetched 2026-05

Policy exposure

Bank-linked ownership and group nexus Its association with the Islami Bank-linked network ties the firm to a financial group whose ownership and governance have drawn regulatory and policy scrutiny, raising related-party and concentration concerns. Source: analysis

Long-standing listing and minority-investor governance As one of the earlier-listed pharma firms (since 1989), its disclosure and board governance set a reference point for investor protection in the sector. Source: Dhaka Stock Exchange, fetched 2026-05

Regulation of herbal and Unani-Ayurvedic products Traditional-medicine product lines fall under a less standardized regulatory regime than allopathic drugs, posing quality-assurance and consumer-safety policy questions. Source: Directorate General of Drug Administration (DGDA)